NATHBIOGEN — Nath Bio-Genes (I) Balance Sheet
0.000.00%
Last trade - 00:00
- IN₹4.69bn
- IN₹3.39bn
- IN₹3.33bn
- 50
- 73
- 64
- 72
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 220 | 292 | 41.7 | 380 | 2,403 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1,176 | 1,133 | 203 | 1,322 | 994 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 4,772 | 5,239 | 4,702 | 5,208 | 5,717 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,309 | 2,333 | 2,329 | 2,340 | 2,406 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 7,299 | 7,895 | 7,419 | 7,928 | 8,802 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1,696 | 1,730 | 1,967 | 2,165 | 2,624 |
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 1,723 | 1,762 | 1,999 | 2,196 | 2,703 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 5,576 | 6,133 | 5,420 | 5,732 | 6,099 |
Total Liabilities & Shareholders' Equity | 7,299 | 7,895 | 7,419 | 7,928 | 8,802 |
Total Common Shares Outstanding |